Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02600897
Brief Title: A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

First Submitted : November 3, 2015
First Submitted that Met QC Criteria : November 5, 2015
First Posted : November 9, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : February 5, 2021
Last Update Posted : February 8, 2021